Explore Stanford technologies available for licensing:

Stanford researchers have developed a novel immunotherapy approach to deplete EBV-infected B cells to provide treatment for EBV-mediated autoimmune diseases.

Stanford scientists have developed an innovative capacitive 6-axis force-torque sensor priced under $10—significantly more affordable than conventional sensors costing $1000+.

Stanford researchers have developed an approach to enhance Phlego cement production by leveraging the Streckeisen (QAPF) diagram, a powerful tool for classifying igneous rocks based on their mineralogical composition.

Stanford researchers have developed a breakthrough technique that renders living biological tissues transparent across the entire visible spectrum.

Stanford researchers have created the Equivalent Expression Index, an innovative computational algorithm that identifies statistically significant equivalently expressed genes to uncover gene expression programs facilitating breast cancer brain metastasis (BACE-45, MIBS-9, ARC

Stanford researchers have developed an innovative microfluidic platform, EV-Lev, for the isolation and sorting of extracellular vesicles (EVs) from human plasma.

Researchers at Stanford have developed a strategy to improve the efficacy of antibiotics by conjugating the antibiotic to a guanidinium-rich molecular transporter (GR-MoTr).

Stanford researchers have repurposed two existing drugs and created a combined nanoparticle formulation that provides both intraocular pressure management and neuroprotection for glaucoma therapy.

Stanford researchers in Prof. Corinne Beinat's lab have developed a novel radiotracer, [18F]hGTS13, for non-invasive imaging of system xc- activity, enabling the identification of ferroptosis-sensitive cancers and monitoring the efficacy of ferroptosis-inducing therapies.

Stanford scientists have developed a trivalent CAR T cell that targets three proteins that are essential for self-renewal and differentiation of leukemic stem cells.

Stanford researchers have developed a powerful immune-based gene expression signature that accurately predicts severe outcomes and all-cause mortality across high-risk populations, enabling personalized treatment selection and advancing precision medicine in critical illnesses

Stanford researchers in the WE3 and S3 Labs developed software for biogas modeling suitable for real-time, co-digestion forecasting control for waste streams with widely varying biodegradability rates.

Stanford researchers have developed a high-resolution, roll-to-roll continuous liquid interface production (r2rCLIP) technology to fabricate advanced microparticles, enabling superior bio-conjugation, barcode detection, and improved stability for more accurate and efficient ce

Stanford scientists have developed SPACE-seq, a novel technology that integrates spatial epigenomics and transcriptomics into a single platform.

Stanford researchers have identified a new therapeutic application for metformin in preventing corticosteroid-associated bone death, or osteonecrosis (ON).